Advanced Hybrid Closed-Loop Technology Could Improve Quality of Life in Type 1 Diabetes
A 1-year observational follow-up of a 3-month randomized controlled trial provides insight into the benefits of advanced hybrid closed-loop system use in people with type 1 diabetes using multiple daily injections and self-monitoring of blood glucose.
Low-Dose Aspirin Could Reduce Diabetes Risk by 15% in Older Patients
Presented as part of the Annual Meeting of the European Association for the Study of Diabetes (EASD) meeting, the study was designed as an analysis of the ASPREE trial.
HPV Vaccination Rates Could Improve With Increased Reimbursement
According to the CDC, HPV is the most commonly sexually transmitted infection in the US, with a prevalence of 45.2% of men and 39.9% of women aged 18-59 in 2013-2014.
Calcium Supplementation and Increased Risk of Death in Older Adults with Cardiovascular Disease
An analysis of data from a Cleveland Clinic database indicates calcium supplementation in older adults with aortic stenosis was linked to an increased risk of mortality and worsening aortic stenosis.
Improving Glycemic Control with Diabetes App Features
A review of data presented at ATTD 2022 dissects what features within smartphone applications created to improve diabetes management actually contribute to improved glycemic control.
Drug Update: FDA Approves Empagliflozin for Adults With Heart Failure
The approval indicates the SGLT2 inhibitor for reducing risk of CV death and hospitalizations for heart failure in adults with heart failure.
2 Clarke Drive Cranbury, NJ 08512